文献速递淋巴瘤

SOX11、CD70与Treg细胞塑造侵袭性套细胞淋巴瘤的肿瘤免疫微环境

SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma.
PubMed 文献 · Blood · 2021-01-01

该研究对730个免疫相关基因进行整合转录组分析,并结合免疫组化表型分析,比较SOX11+与SOX11-原发淋巴结套细胞淋巴瘤(MCL)及反应性淋巴结。SOX11+ MCL瘤内T细胞浸润显著降低,CD70为SOX11直接靶基因,其过表达与效应性Treg细胞浸润增加、高增殖及侵袭性临床病程相关,提示SOX11与免疫抑制微环境相关。

要点

  • SOX11+ MCL较SOX11-病例瘤内T细胞浸润显著减少。
  • CD70为SOX11直接靶基因,在SOX11+肿瘤细胞中经CD40L诱导过表达。
  • CD70过表达与效应性Treg细胞浸润增加及侵袭性临床病程相关。

核心结论

  • SOX11表达与MCL免疫抑制微环境相关,特征为肿瘤细胞CD70过表达、Treg细胞浸润增加及抗原加工提呈和T细胞活化下调。

研究设计与样本

  • 对730个免疫相关基因进行整合转录组分析,并结合免疫组化免疫细胞表型分析,比较SOX11+与SOX11-原发淋巴结MCL及非肿瘤反应性淋巴结。

主要发现

  • SOX11+ MCL较SOX11-病例的瘤内T细胞浸润显著降低。
  • MHC I/II类样及T细胞共刺激和信号活化相关转录本表达降低与不良临床结局显著相关。
  • CD70为SOX11直接靶基因,体外经CD40L诱导在SOX11+而非SOX11-肿瘤细胞中过表达。
  • CD70在SOX11+原发MCL中过表达,与效应性Treg细胞浸润增加、更高增殖及侵袭性临床病程相关。
  • CD27在76%的病例中以中等至强强度表达。

关键数值与推荐

  • CD27在76%的病例中以中等至强强度表达。

临床怎么用

  • SOX11与CD70及Treg细胞构成的免疫抑制微环境可能促进MCL进展,并可作为个体化治疗的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mantle cell lymphoma (MCL) is a mature B-cell neoplasm with a heterogeneous clinical and biological behavior. SOX11 oncogenic expression contributes to the aggressiveness of these tumors by different mechanisms, including tumor and stromal cell interactions. However, the precise composition of the immune cell microenvironment of MCL, its possible relationship to SOX11 expression, and how it may contribute to tumor behavior is not well known. Here, we performed an integrative transcriptome analysis of 730 immune-related genes combined with the immune cell phenotype analysis by immunohistochemistry in SOX11+ and SOX11- primary nodal MCL cases and non-neoplastic reactive lymph nodes. SOX11+ MCL had a significant lower T-cell intratumoral infiltration compared with negative cases. A reduced expression of MHCI/II-like and T-cell costimulation and signaling activation related transcripts was significantly associated with poor clinical outcome. Moreover, we identified CD70 as a SOX11 direct target gene, whose overexpression was induced in SOX11+, but not SOX11- tumor cells by CD40L in vitro. CD70 was overexpressed in primary SOX11+ MCL and it was associated with an immune unbalance of the tumor microenvironment characterized by increased number of effector regulatory t (Treg) cell infiltration, higher proliferation, and aggressive clinical course. CD27 was expressed with moderate to strong intensity in 76% of cases. Overall, our results suggest that SOX11 expression in MCL is associated with an immunosuppressive microenvironment characterized by CD70 overexpression in tumor cells, increased Treg cell infiltration and downmodulation of antigen processing, and presentation and T-cell activation that could promote MCL progression and represent a potential target for tailored therapies.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Balsas P, Veloza L, Clot G, et al. SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma. Blood. 2021. PMID: 34189576. doi:10.1182/blood.2020010527

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。